Physician factors associated with inappropriate vitamin B12 prescribing in Ontario, Canada

Abstract not available.

View Source

Information

Citation

Silverstein WK, Lin Y, Dharma C, Croxford R, Cheung MC. J Gen Intern Med. 2021; 36(9):2888-90. Epub 2020 Sep 9.

View Source

Discover More

Journal Article

28/11/2023

Family physician count and service provision in Ontario and Alberta between 2005/06 and 2017/18: a cross-sectional study

McDonald T, Schultz SE, Green LA, Lethebe BC, Glazier RH. CMAJ Open. 2023; 11(6):E1102-8. Epub 2023 Nov 28.

Journal Article

27/11/2023

Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease

Muanda FT, Blake PG, Weir MA, Ahmadi F, McArthur E, Sontrop JM, Urquhart BL, Kim RB, Garg AX. JAMA Netw Open. 2023; 6(11):e2345132. Epub 2023 Nov 27.

Journal Article

27/11/2023

Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: a population-based cohort study

Rochon PA, Austin PC, Normand SL, Savage RD, Read SH, McCarthy LM, Giannakeas V, Wu W, Strauss R, Wang X, Chen S, Gurwitz JH. J Am Geriatr Soc. 2023; Nov 27 [Epub ahead of print].

See All

Physician factors associated with inappropriate vitamin B12 prescribing in Ontario, Canada

Information

Citation

Contributing ICES Scientists

Research Programs

Associated Sites

Discover More

Family physician count and service provision in Ontario and Alberta between 2005/06 and 2017/18: a cross-sectional study

Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease

Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: a population-based cohort study